# NUWELLIS, INC. (NUWE) · Edgar & Edgarette company card

> Nuwellis (NUWE) saw revenue fall 5.4% in FY2025 to $8 million, operating margin -134% against a 7.5% median for electromedical & electrotherapeutic apparatus, equity 42.9% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1506492 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/NUWE) · [JSON](https://www.pops4.com/boards/company/NUWE.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $8M |
| Revenue growth, 1 year | -5.4% |
| Revenue growth per year | 1.1% |
| Operating margin | -134.3% (prior year -125.7%) |
| Net margin | -211.9% |
| Operating cash flow | −$11M |
| Capital spending | $90,000 |
| Free cash flow | −$11M |
| Cash | $1M |
| Long-term debt | — |
| Total assets | $6M |
| Total equity | $3M |
| Equity ÷ assets | 42.9% |
| Return on equity | -667.7% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -177.65 (distress zone)
- Piotroski F: 3 of 9 (middling)
- Beneish M: -7.72 (below the −1.78 line)
- Health Harbor boat: Old boat · three warning signs · operating cash flow was negative; operating loss: a margin of -134.3% in FY2025; revenue is hard to predict: its 80% range is ±39%
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $8.3M (FY2025). Experience: revenue down 5.4% on the year, up 1.1% a year over 4 years; operating margin -134.3%, down from -125.7%. Soundness: equity 42.9% of assets, return on equity -667.7%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $5.2M and $11.8M next year (method v4.1: its own 6-year record of growth weighed at 63% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $4.9M to $12.5M. A statistical range, not company guidance. Against peers (13 filers, $50M+ revenue, electromedical & electrotherapeutic apparatus): operating margin -134.3% against a 7.5% median; growth -5.4% against 8.3%.

Range logged 2026-09-27, receipt 5033929b3ad075f6, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 5, latest 2026-06-18 ([filing](https://www.sec.gov/Archives/edgar/data/1506492/000114036126025614/0001140361-26-025614-index.htm))

## Recent filings

- 8-K · filed 2026-10-23 · 3.03 Material Modifications to Rights of Security Holders; 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1506492/000114036126040605/0001140361-26-040605-index.htm)
- 8-K · filed 2026-08-26 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1506492/000114036126034367/0001140361-26-034367-index.htm)
- 8-K · filed 2026-08-13 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1506492/000114036126032838/0001140361-26-032838-index.htm)
- 10-Q · filed 2026-08-13 · [filing](https://www.sec.gov/Archives/edgar/data/1506492/000114036126032810/0001140361-26-032810-index.htm)
- 8-K · filed 2026-08-03 · 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1506492/000114036126030985/0001140361-26-030985-index.htm)
- 8-K · filed 2026-07-24 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/1506492/000114036126029609/0001140361-26-029609-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001506492.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1506492

## Cite

POPS4, Edgar & Edgarette: NUWELLIS, INC. (NUWE) company card, from the company's own SEC filings, accessed 2026-11-12, https://www.pops4.com/boards/company/NUWE. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.